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Abstract
Background: Indonesia ranks the second highest in blindness worldwide. One of the factors that may cause 
blindness is posterior capsule opacification (PCO), a secondary cataract that developed after cataract surgery. PCO eventually leads to visual impairment. The common management for PCO is neodymium:yttrium-
aluminium-garnet (Nd:YAG) laser posterior capsulotomy. It is an effective, non-invasive, and painless 
procedure. The aim of this study was to describe the visual acuity of PCO patients after Nd: YAG laser posterior capsulotomy. 
Methods: A descriptive study was conducted based on simple randomized secondary data from Cicendo Eye Hospital, Bandung from January 2013 to August 2014. 
Results: Out of 102 patients, 53 patients (51.96%) were male and 49  (48.04%) were females. The male to 
female ratio was 1:1. The maximum number of patients was at age group of 60−69 years (33.33%). Sixty−
nine patients (67.65%) presented mild or no visual impairment uncorrected visual acuity (UCVA) post-
laser. Eighty-nine patients (87.25%) presented mild or no visual impairment best-corrected visual acuity 
(BCVA) post-laser. Generally, 94 patients (92.16%) showed improvement of visual acuity after Nd:YAG laser 
posterior capsulotomy. Three patients (2.49%) were suffering from blindness UCVA post-laser and 1 patient 
(0.98%) falls at blindness BCVA post-laser respectively.
Conclusions: Improvement of visual acuity is achieved after Nd:YAG laser posterior capsulotomy in PCO patients. [AMJ.2016;3(1):99–102]
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IntroductionAccording to the World Health Organization 
(WHO), approximately 285 million people in the world are visually impaired. This 
includes 39 million people are blind and 246 
million people are having low vision. Globally, cataract is the second major cause of visual 
impairment, which occupied 33%.1,2 Indonesia is the second country with the highest rate of blindness in the world, which is  around 1.5 percent of the population, or 3.5 million people , who are listed as legally blind. Cataract is an opacity of the crystalline lens of the eye or its capsule.3 To remove the opacification a cataract surgery is needed. However, there is a common complication for this surgery, the 
posterior capsule opacification (PCO).4 The PCO is a development of opacity or 
clouding at the posterior part of the capsule. It obstructs the light passage, and causes visual impairment. The incidence of PCO around 
the world is 20% within a year after cataract 
surgery and 50% five years after surgery. The risk factors of PCO are the type of lens and 
young age. Some studies show the growth of the epithelial cells of young people is more than elderly.4 There is a simple and effective procedure, neodymium:yttrium-aluminium-
garnet (Nd:YAG) laser posterior capsulatomy, which is indicated to treat posterior capsule 
opacification. This Nd:YAG laser is focus at the 
center of the opacified posterior capsule, and an opening is formed, therefore the light can pass though the capsule, and lead to a clear vision.5 Therefore, a study was conducted to 
describe the visual outcome of Nd:YAG laser posterior capsulatomy in posterior capsule 
opacification patients at Cicendo Eye Hospital 
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from January 2013 to August 2014.
MethodsA descriptive study was conducted and data collected from January 2013 to August 2014 by using the retrospective method at Cicendo Eye Hospital Bandung. The study population was the patients who were admitted to Cicendo National Eye Hospital Bandung with posterior 
capsule opacification and were treated with 
Nd:YAG laser posterior capsulatomy from January 2013 to August 2014. The samples were selected using the simple random sampling method.The samples were taken from the medical records with certain inclusion and exclusion criteria. Inclusion Criteria were such as the medical records of posterior capsule 
opacification patients with completed visual acuity data and completed with 1 week postoperative follow up. The medical records 
of posterior capsule opacification patients with eye diseases other than posterior capsule 
opacification or treated with operations other 
than Nd:YAG laser posterior capsulatomy were excluded from the study.The variables included gender, age, and visual acuity. Thus, the patients were categorized into male and female. For the age group, the patients were categorized 
into age 0−9, 10−19, 20−29, 30−39, 40−49, 
50−59, 60−69, 70−79, and 80−89 years old. Meanwhile, the visual acuity of the patients was categorized according to the WHO visual 
acuity classification, no light perception, 
0−˂0.02, 0.02−˂0.05, 0.05−˂0.1, 0.1−˂.03, 
0.3−1.The study instrument was the medical 
records of posterior capsule opacification 
patients who were treated with Nd:YAG laser posterior capsulatomy at Cicendo Eye Hospital from January 2013 to August 2014. Furthermore, the medical records that met the inclusion and exclusion criteria were categorized into variables and calculated to 
obtain the percentage. Data collected from the medical records included the gender, 
age, preoperative UCVA, preoperative BCVA, 
postoperative UCVA, and postoperative BCVA. Then, the percentage of each variable in the total of patients was calculated.Additionally, the information of patients 
taken from medical records was confidential to protect the patients’ privacy.
Results
Out of 102 patients, 53 patients (51.96%) 
were male and 49 (48.04%) were females. The male to female ratio was 1:1. The maximum number of patients was at 
the age group of 60-69 years, which occupied 
by 34 patients (33.33%).
Sixty-nine patients (67.65%) presented mild or no visual impairment uncorrected 
visual acuity (UCVA) post-laser. Eighty-nine 
patients (87.25%) presented mild or no visual impairment best-corrected visual acuity 
(BCVA) post-laser. Three patients (2.49%) 
were suffering from blindness UCVA post-
laser and 1 patient (0.98%) falls at blindness 
BCVA post-laser respectively. Generally, 94 
patients (92.16%) showed improvement of 
visual acuity after Nd:YAG laser posterior capsulotomy.
Discussion 
The emergence of Nd:YAG laser in the management of PCO, has improved the visual outcome of cataract surgeries. Fifty three 
patients (51.96%) were males and 49 patients 
(48.04%) were females (Table 1). The male to female ratio was 1:1. Based on a previous study, 
there  were 47 male patients (52.2%) and 43 
females patients (47.8%), the male to female ratio was equal to 1:1, these results were the same as in this study. Another study  also showed almost similar sex ratio.6 This is due to the leading cause of blindness worldwide, that cataract occurs equally among male and 
Table 1Gender of Patients who had Undergone Nd: YAG Laser Posterior Capsulotomy from 
  January 2013 to August 2014.
Gender Frequency %Male 53 51.96Female 49 48.04Total 102 100.00
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female, thus when routine cataract surgeries are performed, complications such as PCO can also occur in equal proportions.7 The maximum number of patients was 
in the age group of 60−69 years (33.33%), 
the second was in the age group of 50−59 
years (21.57%) with 22 patients, then in the 
age group of 70−79 years (16.17%) with 17 
patients. A total 71.07% of patients were at 
the range of 50-79 years, this may due to these patients had consulted the Ophthalmologist 
with age related cataract (Table 2). Based on 
a previous study, most patients (77.8%) were 
in the 41−80 years age range. It showed a wider age range, this was due to wider setting 
of age range (20 years) in the previous study, whereas this study applied a smaller age range 
(10 years) to show more accurate and precise results.7 At the same time, another previous study showed that the average age of patients 
was 76.49 years.8 
 After the treatment of Nd: YAG laser posterior capsulotomy, both number of patients in mild 
and  no visual impairment of BCVA and UCVA 
were the highest  numbers, which were 69 
patients (67.65%) and 89 patients (87.25%) 
respectively. In general, 94 patients (92.16%) 
had significant improvement of vision outcome 
after Nd: YAG laser capsulotomy (Table 3). 
Based a on previous study, 97% patients were having improved visual acuity, which was higher than in this study, this was probably due to the threemonth follow-up after the Nd: 
YAG laser capsulotomy. Meanwhile, the data available for this study was limited, which was 
one week follow-up after the Nd: YAG laser capsulotomy.9 Based on another previous 
study, most of the patients (86%) showed improved visual acuity, which was lower than 
in this study (92.16%), but this may be due to 
Table 2 Age of Patients who had Undergone Nd: YAG Laser Posterior Capsulotomy from 
  January 2013 to August 2014.
Age (in years) Frequency %
0−9 3 2.94
10−19 6 5.88
20−29 3 2.94
30−39 1 0.98
40−49 10 9.80
50−59 22 21.57
60−69 34 33.33
70−79 17 16.17
80−89 6 5.88Total 102 100.00
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Table 3 UCVA dan BCVA 1 Week Pre-laser and Post-laser
UCVA
Frequency (%)
UCVA BCVA
Pre-laser Post laser Pre-laser Post-laserNLP 0 0 0 0
0−˂0.02 0 0 0 0
0.02−˂0.05 12 (11.76) 3 (2.49) 7 (6.86) 1 (0.98)
0.05−˂0.1 14 (13.73) 4 (3.92) 7 (6.86) 2 (1.96)
0.1−˂0.3 38 (37.52) 26 (25.49) 25 (24.51) 10 (9.80)
0.3−1.0 38 (37.52) 69 (67.65) 63 (61.76) 89 (87.25)Total 102 (100.00) 102 (100.00) 102 (100.00) 102 (100.00)
Note: *UCVA=uncorrected visual acuity, *BCVA=best-corrected visual acuity
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the larger sample size, the 86% means 160 patients out of 200 patients.10 
However, 3 patients (2.49%) were having 
BCVA blindness and 1 patient (0.98%) was 
having UCVA blindness respectively, even though they were treated with the laser. These non-improvements in vision outcome may be attributable to the presence of media opacities or other ocular pathology which were not detected earlier before the procedure. 
Based on a previous study, 5 patients (5.6%) presented with visual acuity of blindness post laser procedure, which was higher than in this study, which probably means currently, Indonesia can provide doctors with better skills, environments for better healing, or increase awareness of public the importance of eyes caring.7Due to lack of time and the great number of uncompleted medical records data may cause the limitations of this study.A few recommendations are suggested after conducting this study. The time assigned for data collection can be prolonged for the sake of adequate sample size. Follow up by the patients after treatment should be demanding to assess the condition of recovery phase, since a lot of patients did not return to the hospital for a follow up in this study. A computerized storage of medical records will provide a lot 
benefit, such as saving space, easy to look for, neat and tidy.In conclusion, the improvement of visual 
acuity is achieved after the Nd:YAG laser posterior capsulotomy in PCO patients at Cicendo Eye Hospital from January 2013 to August 2014.
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